{"id":"https://openalex.org/W7098074232","doi":null,"title":"Incretin-Based Therapies A Clinical Need Filled by Unique Metabolic Effects Learning Objectives","display_name":"Incretin-Based Therapies A Clinical Need Filled by Unique Metabolic Effects Learning Objectives","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7098074232"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.730.7866","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.730.7866","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.glucagon.com/pdfs/DiabetesEducator2006Incretin-basedtherapies.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7098074232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057472647","display_name":"Daniel J. Drucker","orcid":"https://orcid.org/0000-0001-6688-8127","observed_orcids":["https://orcid.org/0000-0001-6688-8127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Drucker Md","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"From The Banting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"From The Banting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Best Diabetes Centre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Best Diabetes Centre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8740000128746033},{"id":"https://openalex.org/keywords/glucose-dependent-insulin-secretion","display_name":"glucose-dependent insulin secretion","score":0.9769999980926514},{"id":"https://openalex.org/keywords/glucagon-suppression","display_name":"glucagon suppression","score":0.8880000114440918},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.8880000114440918},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9950000047683716},{"id":"https://openalex.org/keywords/diabetes-epidemic","display_name":"diabetes epidemic","score":0.5109999775886536},{"id":"https://openalex.org/keywords/diabetes-costs","display_name":"diabetes costs","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8657000064849854},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7641000151634216},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6965000033378601},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6484000086784363},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.628600001335144},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.5378999710083008},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4390000104904175},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.4235999882221222},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.32409998774528503},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.31450000405311584},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.3077000081539154},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.30059999227523804},{"id":"https://openalex.org/C2779668308","wikidata":"https://www.wikidata.org/wiki/Q2087205","display_name":"Prediabetes","level":4,"score":0.258899986743927},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.25369998812675476}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.730.7866","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.730.7866","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.glucagon.com/pdfs/DiabetesEducator2006Incretin-basedtherapies.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1518474484","https://openalex.org/W2035966484","https://openalex.org/W1701345","https://openalex.org/W2184554839","https://openalex.org/W2134760433","https://openalex.org/W147529274","https://openalex.org/W4383740618","https://openalex.org/W2167239693","https://openalex.org/W2087597197"],"abstract_inverted_index":{"\u2022":[0,12,25],"List":[1],"the":[2,14,27,38,77,107,118,125,140,151,176],"2":[3,10,23,84,122],"major":[4],"pathophysiologic":[5,79],"defects":[6,80],"associated":[7,81],"with":[8,37,82],"type":[9,22,83,121],"diabetes.":[11,24],"Discuss":[13],"barriers":[15],"to":[16,145],"achieving":[17],"tight":[18,52],"glycemic":[19,63],"control":[20],"in":[21,139,156,175,179,185],"Describe":[26],"effects":[28,92],"of":[29,41,58,76,97,102,109,120,150,173],"incretin":[30],"hormones":[31],"on":[32,93],"glucose":[33,53],"metabolism.":[34],"In":[35,133],"conjunction":[36],"rising":[39],"prevalence":[40],"dia-betes,":[42],"there":[43],"is":[44],"an":[45,56],"urgent":[46],"need":[47],"for":[48,68],"strategies":[49],"that":[50],"pro-mote":[51],"control,":[54],"as":[55],"overwhelmingmajority":[57],"patients":[59],"are":[60],"not":[61],"meeting":[62],"tar-gets.":[64],"Many":[65],"current":[66],"options":[67],"intensive":[69],"diabetes":[70,123,147,154,174],"thera-py":[71],"address":[72,117],"only":[73],"one":[74],"aspect":[75],"underlying":[78,127],"dia-betes.":[85],"The":[86,130,170],"new":[87],"incretin-based":[88,128],"therapies":[89],"offer":[90],"unique":[91],"metabolism,":[94],"including":[95,161],"stimulation":[96],"glucose-dependent":[98],"insulin":[99],"secretion,":[100,105],"suppression":[101],"postprandial":[103],"glucagon":[104],"and":[106,111,124,159,168],"promotion":[108],"satiety":[110],"weight":[112],"loss.":[113],"This":[114],"review":[115],"will":[116],"pathophysiolo-gy":[119],"rationale":[126],"therapies.":[129],"Diabetes":[131],"Epidemic":[132],"2002,":[134],"nearly":[135,182],"18.2":[136],"million":[137],"people":[138],"United":[141,177],"States":[142,178],"were":[143],"believed":[144],"have":[146],"(\u223c6.3":[148],"%":[149],"pop-ulation).1":[152],"Uncontrolled":[153],"results":[155],"significant":[157],"morbidity":[158],"mortality,":[160],"cardiovascular":[162],"dis-ease,":[163],"blindness,":[164],"end-stage":[165],"renal":[166],"disease,":[167],"amputa-tions.1":[169],"total":[171],"cost":[172],"2002":[180],"was":[181],"$132":[183],"billion":[184],"medical":[186],"expenditures":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7098074232","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-27T00:00:00"}
